Amber Salzman, Ph.D.
Advertisement
Amber Salzman, Ph.D., is the president and CEO of Ohana Biosciences.
Articles by Amber Salzman, Ph.D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Challenges in Oral Delivery of Peptides: Bioavailability
2
Manufacturing Intelligence: Where Pharma Should Slow AI
3
AstraZeneca Secures 2 FDA Approvals in Bladder Cancer, Myasthenia Gravis
4
Giredestrant Takes ESR1 Breast Cancer Treatment Into Oral Solid Doses
5

